US Bancorp’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-666
Closed -$679 4160
2023
Q3
$679 Hold
666
﹤0.01% 3821
2023
Q2
$806 Hold
666
﹤0.01% 3830
2023
Q1
$666 Hold
666
﹤0.01% 3920
2022
Q4
$566 Hold
666
﹤0.01% 3987
2022
Q3
$2K Sell
666
-1
-0.1% -$5 ﹤0.01% 3873
2022
Q2
$4K Hold
667
﹤0.01% 3673
2022
Q1
$3K Hold
667
﹤0.01% 3772
2021
Q4
$3K Hold
667
﹤0.01% 3835
2021
Q3
$6K Hold
667
﹤0.01% 3607
2021
Q2
$10K Buy
+667
New +$12.9K ﹤0.01% 3408
2021
Q1
Sell
-333
Closed -$2K 3967
2020
Q4
$2K Buy
333
+125
+60% +$442 ﹤0.01% 3609
2020
Q3
$1K Hold
208
﹤0.01% 3639
2020
Q2
$1K Hold
208
﹤0.01% 3653
2020
Q1
$1K Hold
208
﹤0.01% 3613
2019
Q4
$4K Hold
208
﹤0.01% 3355
2019
Q3
$4K Hold
208
﹤0.01% 3301
2019
Q2
$4K Hold
208
﹤0.01% 3336
2019
Q1
$4K Hold
208
﹤0.01% 3305
2018
Q4
$4K Hold
208
﹤0.01% 3278
2018
Q3
$10K Hold
208
﹤0.01% 3128
2018
Q2
$8K Hold
208
﹤0.01% 3208
2018
Q1
$10K Hold
208
﹤0.01% 3158
2017
Q4
$10K Buy
+208
New +$6.91K ﹤0.01% 3146

Other funds holding VANI

US Bancorp's VANI Position: Q4 2023 in Review

US Bancorp sold out of Vivani Medical (VANI) in Q4 2023, closing a stake of 666 shares — an estimated $679 sold.

US Bancorp first reported a position in VANI in Q4 2017 and held it in 23 quarters. The position peaked at $10K in Q2 2021. 31 funds tracked by Wall St. Rank hold VANI as of Q4 2023.

  • US Bancorp reported no remaining Vivani Medical position as of Q4 2023 after selling out during the quarter.
  • US Bancorp sold 666 Vivani Medical shares in Q4 2023, an estimated $679.
  • US Bancorp first reported a position in Vivani Medical in Q4 2017 and held it in 23 quarters.
  • US Bancorp's Vivani Medical position peaked at $10K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.